Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 12, 2013

Leica and Synthon Collaborate on Cancer CDx

  • Leica Biosystems and Synthon Biopharmaceuticals have partnered to develop a companion diagnostic program for targeted cancer therapies. Leica will develop a fully automated tissue-based companion diagnostic test to run on its BOND™ automated advanced staining systems paired with one of Synthon’s antibody-drug conjugates, to enhance the treatment of solid tumors.

    In December 2012, Leica Biosystems teamed up with Galena Biopharma to develop a companion diagnostic for Galena's NeuVax™ (nelipepimut-S or E75) breast cancer therapeutic. Leica's Bond Oracle™ Human Epidermal Growth Factor Receptor 2 (HER2) IHC System companion diagnostic was used to support the selection of the patients for the NeuVax Phase III PRESENT study.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »